Safety concerns with J&J’s COVID-19 vaccine present a big opportunity for Pfizer, Moderna: analyst kdunleavy Thu, 04/15/2021 – 09:38 More: Safety concerns with J&J's COVID-19 vaccine present a big opportunity for Pfizer, Moderna: analyst Source: fierce
read moreAlexion’s pricey Ultomiris wins backing from England’s cost watchdogs thanks to confidential discount aliu Thu, 04/15/2021 – 09:34 More: Alexion's pricey Ultomiris wins backing from England's cost watchdogs thanks to confidential discount Source: fierce
read moreThe funding will be used to advance Alchemab’s novel platform to identify disease-modifying antibody therapeutics More: Alchemab completes £60m Series A funding to advance novel antibody platform Source: News
read moreResearchers from Imperial College London say compound is at least as effective as a leading antidepressant in a therapeutic setting More: Magic mushroom compound psilocybin shows ‘promise’ in depression Source: News
read moreThe previously-reported CENTAUR study of AMX0035 in 137 participants with ALS met its primary endpoint of slowing ALS progression More: Amylyx Pharma plans to file ALS therapy with the EMA this year Source: News
read moreBritish drugmaker has discontinued treatment with investigational drug in two cancer trials More: GSK decides to halt mid-stage feladilimab studies Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals